Drug points: Dysgeusia and burning mouth syndrome by eprosartan
- PMID: 12458247
- PMCID: PMC136926
- DOI: 10.1136/bmj.325.7375.1277
Drug points: Dysgeusia and burning mouth syndrome by eprosartan
Similar articles
-
Interstitial pneumonitis secondary to eprosartan.Arch Bronconeumol. 2012 Dec;48(12):485. doi: 10.1016/j.arbres.2012.06.004. Epub 2012 Jul 31. Arch Bronconeumol. 2012. PMID: 22858302 English, Spanish. No abstract available.
-
Safety and tolerability of eprosartan.Pharmacotherapy. 1999 Apr;19(4 Pt 2):102S-107S. doi: 10.1592/phco.19.7.102s.30945. Pharmacotherapy. 1999. PMID: 10213529 Review.
-
Eprosartan.Drugs. 1998 May;55(5):713-8; discussion 719-20. doi: 10.2165/00003495-199855050-00011. Drugs. 1998. PMID: 9585867 Review.
-
Celiac disease-like enteropathy due to antihypertensive therapy with the angiotensin-II receptor type 1 inhibitor eprosartan.Cesk Patol. 2015;51(2):87-8. Cesk Patol. 2015. PMID: 25970720
-
Safety and tolerability of eprosartan in combination with hydrochlorothiazide.Drug Saf. 2002;25(8):599-611. doi: 10.2165/00002018-200225080-00005. Drug Saf. 2002. PMID: 12113644 Review.
Cited by
-
Is Dysguesia Going to be a Rare or a Common Side-effect of Amlodipine?Ann Med Health Sci Res. 2014 Mar;4(Suppl 1):S43-4. doi: 10.4103/2141-9248.131714. Ann Med Health Sci Res. 2014. PMID: 25031906 Free PMC article.
-
Antiarrhythmic drug-induced smell and taste disturbances: A case report and literature review.Medicine (Baltimore). 2018 Jul;97(29):e11112. doi: 10.1097/MD.0000000000011112. Medicine (Baltimore). 2018. PMID: 30024498 Free PMC article. Review.
References
-
- Henkin RI. Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarly to treatment of sensory receptor dysfunction. Drug Saf. 1994;11:318–377. - PubMed
-
- Mazzolai L, Burnier M. Comparative safety and tolerability of angiotensin II-receptor antagonists. Drug Saf. 1999;21:23–33. - PubMed
-
- Malnick SD, Becker S. Dysgeusia by losartan in a patient intolerant of captopril. Med Gen Med. 1999;4:E33. - PubMed
-
- Schlienger RG, Saxer MS, Haefeli WE. Reversible dysgeusia associated with losartan. Lancet. 1996;347:471–472. - PubMed
-
- Heeringa M, van Puijenbroek EP. Reversible dysgeusia attributed to losartan. Ann Intern Med. 1998;129:72. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical